Data / Form D filings / Zocere Inc.
Zocere Inc.: Form D filings
Zocere Inc., a pharmaceuticals company in Albuquerque, NM, filed 3 Form D notices with the SEC between 2013 and 2015. The latest, on March 31, 2015, reports an offering of $300,000 with nothing sold yet.
Find out what Zocere Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 801 UNIVERSITY BLVD, SUITE 100, Albuquerque, NM, 87106
- Phone
- (505) 272-7041
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1587644
The full lists. Form D filings in New Mexico: 56 rows, $5, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2015 | New notice | $300,000 | $0 | $300,000 | 0 | Yet to occur | sec.gov |
| Sep 26, 2013 | Amendment | $250,000 | $100,000 | $150,000 | 6 | Jul 17, 2013 | sec.gov |
| Sep 25, 2013 | New notice | $250,000 | $100,000 | $150,000 | 6 | Jul 17, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JOHN CHAVEZ | Director | |
| WAYNE LASLIE | Executive Officer, Director | |
| ADRIAN HOBDEN | Director | |
| ALAN KOLOD | Executive Officer |
Every Form D from the week of Mar 30, 2015 · All recent filings in New Mexico · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Zocere Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.